Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Gaza ceasefire brings limited relief as cash crisis persists, with many unable to return home and tensions rising over hostage exchanges.
Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
Gaza ceasefire brings limited relief as cash crisis persists, with many unable to return home and tensions rising over hostage exchanges.